Neurotech International Limited (ASX:NTI)
Australia flag Australia · Delayed Price · Currency is AUD
0.0130
0.00 (0.00%)
Apr 17, 2026, 4:10 PM AEST

Neurotech International Revenue

Neurotech International had revenue of 4.74M AUD in the half year ending December 31, 2025, with 47.68% growth. This brings the company's revenue in the last twelve months to 7.07M, up 8,687.82% year-over-year. In the fiscal year ending June 30, 2025, Neurotech International had annual revenue of 2.44M, down -23.07%.

Revenue (ttm)
7.07M
Revenue Growth
+8,687.82%
P/S Ratio
2.42
Revenue / Employee
n/a
Employees
n/a
Market Cap
17.13M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20252.44M-732.95K-23.07%
Jun 30, 20243.18M1.98M166.00%
Jun 30, 20231.19M586.87K96.59%
Jun 30, 2022607.62K401.25K194.44%
Jun 30, 2021206.37K126.03K156.86%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Immuron7.48M
Noxopharm3.40M
Tissue Repair3.38M
Avecho Biotechnology1.24M
Argenica Therapeutics1.01M
AdAlta608.07K
Bio-Gene Technology390.63K
Patrys100.38K
Revenue Rankings